“Distribution of SALT Scores With Ritlecitinib Treatment up to 24 Months from the ALLEGRO Phase 2b 3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s465. Accessed October 26, 2025. https://skin.dermsquared.com/skin/article/view/3084.